Process evaluation and early outcomes of real-world implementation of a pharmacist-driven cabotegravir/rilpivirine long-acting injectable initiative

被引：1
|
作者：
Derrick, Caroline B. [1 ]
Magee, Matthew [2 ]
Tsai, Y. Vivian [3 ]
Pizzuti, Morgan E. [4 ]
Parker, Sarah [2 ]
Lucas, Omar [1 ]
Taylor, Kara [5 ]
Albright, Raeghan [6 ]
Langehans, Briley [7 ]
Schreiber, Danny [8 ]
Guest, Georgia [8 ]
Ahuja, Divya [1 ]
Weissman, Sharon [1 ]
机构：
[1] SC Univ South Carolina, Sch Med Columbia, Prisma Hlth Richland Columbia, Columbia, SC 29208 USA
[2] Univ South Carolina, Sch Med Columbia, Columbia, SC USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Prisma Hlth Richland Columbia, Columbia, SC USA
[5] WakeMed Hlth Raleigh, Raleigh, NC USA
[6] Publix Pharm Columbia, Columbia, SC USA
[7] Trident Med Ctr Charleston, Charleston, SC USA
[8] Univ South Carolina, Coll Pharm Columbia, Columbia, SC USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2024年
关键词：
cabotegravir; HIV-1; human immunodeficiency virus; pharmacist; resistance; rilpivirine; VIROLOGICAL FAILURE; HIV-1; INFECTION; RILPIVIRINE;
D O I：
10.1093/ajhp/zxae260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation
    Wood, Brian R.
    Kassaye, Seble G.
    Gerstoft, Jan
    AIDS, 2023, 37 (04) : 689 - 691
  • [2] REAL-WORLD PRESCRIBING OF LONG-ACTING INJECTABLE CABOTEGRAVIR FOR TREATMENT OF HIV IN THE UNITED STATES
    Rodriguez, P.
    Cartwright, B.
    Gratzl, S.
    Stucky, N.
    VALUE IN HEALTH, 2023, 26 (12) : S304 - S304
  • [3] Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS)
    John, M.
    Williams, L.
    Nolan, G.
    Bonnett, M.
    Castley, A.
    Nolan, D.
    HIV MEDICINE, 2024, 25 (08) : 935 - 945
  • [4] The optimum implementation of long-acting injectable cabotegravir-rilpivirine in sub-Saharan Africa
    Dawood, Halima
    LANCET GLOBAL HEALTH, 2021, 9 (05): : E563 - E564
  • [5] Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)
    Jonsson-Oldenbuettel, C.
    Ghosn, J.
    Sierra, J. Olalla
    van der Valk, M.
    Lutz, T.
    Belkhir, L.
    van Welzen, B. J.
    Hove, K.
    Ait-Khaled, M.
    DeMoor, R.
    Bontempo, G.
    Latham, C. L.
    Ngenzi, B.
    Okoli, C.
    Gutner, C. A.
    Iyer, S.
    Gill, M.
    Czarnogorski, M.
    D'Amico, R.
    van Wyk, J.
    HIV MEDICINE, 2023, 24 : 193 - 195
  • [6] Early adopters of long-acting injectable cabotegravir/rilpivirine: what lessons can we learn?
    Wood, Brian R.
    Kumarasamy, Nagalingeswaran
    AIDS, 2024, 38 (03) : 425 - 426
  • [7] Real world use of long-acting cabotegravir and rilpivirine in a HIV centre in Hong Kong
    Chan, M. C. J.
    Chik, S. H. T.
    Lamb, S. S.
    Choi, Y. C. C.
    Lau, W. T. A.
    Leung, C. S. E.
    To, P. Y. L.
    Lau, P. L. D.
    Tsang, T. Y. O.
    HIV MEDICINE, 2023, 24 : 155 - 156
  • [8] Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
    Howe, Zach W.
    Norman, Sarah
    Lueken, Abbie F.
    Huesgen, Emily
    Farmer, Eric K.
    Jarrell, Kaitlyn
    Mathis, Joscelyn E.
    Bonham, Kyle W.
    Hahn, Julie
    PHARMACOTHERAPY, 2021, 41 (08): : 686 - 699
  • [9] Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results
    Serris, Alexandra
    Ferre, Valentine Marie
    Le Hingrat, Quentin
    Bachelard, Antoine
    Charpentier, Charlotte
    Exarchopoulos, Marina
    Damond, Florence
    Phung, Bao-Chau
    Landman, Roland
    Yazdanpanah, Yazdan
    Descamps, Diane
    Joly, Veronique
    Peytavin, Gilles
    Ghosn, Jade
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (11) : 2932 - 2938
  • [10] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
    Troya, Jesus
    Morano, Luis
    Ignacio Bernardino, Jose
    Buzon Martin, Luis
    Pedrero Tome, Roberto
    Galindo Puerto, Maria Jose
    Torralba, Miguel
    Cabello Clotet, Noemi
    Garcia Lopez, Maria
    Lope, Silvia
    de Zarraga Fernandez, Miguel Alberto
    Cabello, Alfonso
    Aguilera Garcia, Maria
    Cecilio, Alvaro
    Diaz de Santiago, Alberto
    Garcinuno Jimenez, Maria Angeles
    Bernal, Enrique
    Lopez Caballero, Maria Teresa
    Calderon Hernaiz, Ruth
    Vivancos Gallego, Maria Jesus
    Omiste Sanvicente, Teresa
    Ferreira Pasos, Eva
    Losa Garcia, Juan Emilio
    Soler Gonzalez, Josefa Francisca
    Antonia Sepulveda, Maria
    Garcia Navarro, Maria del Mar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
12345